Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W Scott

Showing results (161-170 of 355) with videos related to

Pageof 36
Sort By:
Leukemia & Lymphoma|April 22, 2023
Population-level impact of ibrutinib for chronic lymphocytic leukemia in British Columbia, CanadaRania S Khelifi, Steven J Huang, Kerry J Savage, et al.
Leukemia & Lymphoma|June 1, 2023
Exploring new prognostic biomarkers in Mantle Cell Lymphoma: a comparison of the circSCORE and the MCL35 scoreRuth Salim, Simon Husby, Christian Winther Eskelund, et al.
Diabetes|October 2, 2009
Tetracycline treatment retards the onset and slows the progression of diabetes in human amylin/islet amyloid polypeptide transgenic miceJacqueline F Aitken, Kerry M Loomes, David W Scott, et al.
British Journal of Haematology|July 23, 2016
Site of central nervous system (CNS) relapse in patients with diffuse large B-cell lymphoma (DLBCL) by the CNS-IPI risk modelRoopesh Kansara, Diego Villa, Alina S Gerrie, et al.
Virchows Archiv : an International Journal of Pathology|November 27, 2016
Aberrant cytoplasmic expression of MHCII confers worse progression free survival in diffuse large B-cell lymphomaSamantha Kendrick, Lisa M Rimsza, David W Scott, et al.
Leukemia & Lymphoma|June 24, 2022
Outcomes after initial refusal of curative treatment in patients with classic Hodgkin lymphomaManik Chahal, Anna Hayden, Kerry J Savage, et al.
Blood Advances|September 9, 2025
Tumor microenvironment differences between diagnostic and relapsed classic Hodgkin lymphoma revealed by scRNA-seqYifan Yin, Shinya Rai, Aixiang Jiang, et al.
Blood|February 15, 2013
The E3 ubiquitin ligase UBR5 is recurrently mutated in mantle cell lymphomaBarbara Meissner, Robert Kridel, Raymond S Lim, et al.
Clinical and Translational Radiation Oncology|October 21, 2024
Maximum disease diameter is associated with outcomes in stage II follicular lymphoma treated with radiation therapy aloneYi Xu, Belinda A Campbell, Matthew Chan, et al.
Blood|January 4, 2014
Variability in DNA methylation defines novel epigenetic subgroups of DLBCL associated with different clinical outcomesNyasha Chambwe, Matthias Kormaksson, Huimin Geng, et al.
Pageof 36

Showing results (161-170 of 355) with videos related to

Sort By:
Pageof 36
Leukemia & Lymphoma|April 22, 2023
Population-level impact of ibrutinib for chronic lymphocytic leukemia in British Columbia, CanadaRania S Khelifi, Steven J Huang, Kerry J Savage, et al.
Leukemia & Lymphoma|June 1, 2023
Exploring new prognostic biomarkers in Mantle Cell Lymphoma: a comparison of the circSCORE and the MCL35 scoreRuth Salim, Simon Husby, Christian Winther Eskelund, et al.
Diabetes|October 2, 2009
Tetracycline treatment retards the onset and slows the progression of diabetes in human amylin/islet amyloid polypeptide transgenic miceJacqueline F Aitken, Kerry M Loomes, David W Scott, et al.
British Journal of Haematology|July 23, 2016
Site of central nervous system (CNS) relapse in patients with diffuse large B-cell lymphoma (DLBCL) by the CNS-IPI risk modelRoopesh Kansara, Diego Villa, Alina S Gerrie, et al.
Virchows Archiv : an International Journal of Pathology|November 27, 2016
Aberrant cytoplasmic expression of MHCII confers worse progression free survival in diffuse large B-cell lymphomaSamantha Kendrick, Lisa M Rimsza, David W Scott, et al.
Leukemia & Lymphoma|June 24, 2022
Outcomes after initial refusal of curative treatment in patients with classic Hodgkin lymphomaManik Chahal, Anna Hayden, Kerry J Savage, et al.
Blood Advances|September 9, 2025
Tumor microenvironment differences between diagnostic and relapsed classic Hodgkin lymphoma revealed by scRNA-seqYifan Yin, Shinya Rai, Aixiang Jiang, et al.
Blood|February 15, 2013
The E3 ubiquitin ligase UBR5 is recurrently mutated in mantle cell lymphomaBarbara Meissner, Robert Kridel, Raymond S Lim, et al.
Clinical and Translational Radiation Oncology|October 21, 2024
Maximum disease diameter is associated with outcomes in stage II follicular lymphoma treated with radiation therapy aloneYi Xu, Belinda A Campbell, Matthew Chan, et al.
Blood|January 4, 2014
Variability in DNA methylation defines novel epigenetic subgroups of DLBCL associated with different clinical outcomesNyasha Chambwe, Matthias Kormaksson, Huimin Geng, et al.
Pageof 36